{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:34:32Z","timestamp":1790418872215,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Alifax, Polverara, PD, Italy","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>A bacteremia diagnosis with speeded-up identification and antimicrobial susceptibility testing (AST) is mandatory to adjust empirical broad-spectrum antibiotherapy and avoid the emergence of multi-resistant bacteria. Alfred 60<jats:sup>AST<\/jats:sup> (Alifax, Polverara, PD, Italy) is an innovative automated system based on light scattering measurements allowing direct AST from positive blood cultures with rapid results. In this study we aimed to evaluate the system\u2019s performances and turnaround time (TAT) compared to routine AST.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study was conducted during 2 non-consecutive 3-month periods at the microbiology laboratory of the Cliniques universitaires Saint-Luc. All blood cultures detected positive in the 0\u2009AM\u201310\u2009AM time frame with a pure Gram-positive cocci or Gram-negative bacilli stain were included for Alfred 60<jats:sup>AST<\/jats:sup> testing. Two customized EUCAST antibiotic panels were set up composed of 1) a \u201cGram-negative\u201d panel including cefuroxime, ceftazidime Enterobacteriaceae, piperacillin-tazobactam Enterobacteriaceae, ciprofloxacine, and ceftazidime <jats:italic>Pseudomonas<\/jats:italic> 2) a \u201cGram-positive\u201d panel including cefoxitin <jats:italic>Staphylococcus aureus<\/jats:italic>, cefoxitin coagulase-negative (CNS) Staphylococci and ampicillin Enterococci. Categorical agreement (CA), very major errors (VME), major errors (ME), minor errors (mE) and TAT to Alfred 60<jats:sup>AST<\/jats:sup> results were calculated in comparison with AST results obtained from direct testing on positive blood cultures with the Phoenix system (Becton Dickinson, Franklin Lakes, NJ, USA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Five hundred seventy and one hundred nine antibiotics were evaluated on respectively 166 Gram-negative bacilli and 109 Gram-positive cocci included in the studied population. During the first study period regarding Gram-negative strains a CA of 89.5% was obtained with a high rate of VME (19 and 15.4% respectively) for cefuroxime and piperacillin-tazobactam Enterobacteriaceae. Considering this, Alifax reviewed these antibiotics\u2019 formulations improving Gram-negative bacilli total CA to 92.2% with no VME during the second study period. For Gram-positive cocci, total CA was 88.1% with 2.3% VME, 13.8% ME (mainly cefoxitin CNS) and 12% mE rates both study periods combined. Median TAT to AST results was 5\u2009h with Alfred versus 12\u2009h34 with Phoenix.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The Alfred 60<jats:sup>AST<\/jats:sup> system shows correct yet improvable microbiological performances and a major TAT reduction compared to direct automated AST testing. Clinical studies measuring the impact of the approach on antibiotic management of patients with bacteremia are recommended.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-019-4623-x","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T17:03:49Z","timestamp":1574355829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Rapid antimicrobial susceptibility testing on positive blood cultures through an innovative light scattering technology: performances and turnaround time evaluation"],"prefix":"10.1186","volume":"19","author":[{"given":"Lidvine","family":"Boland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corentin","family":"Streel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"De Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5486-964X","authenticated-orcid":false,"given":"Alexia","family":"Verroken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"issue":"8","key":"4623_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"8","key":"4623_CR2","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jama.2016.0289","volume":"315","author":"M Shankar-Hari","year":"2016","unstructured":"Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):775\u201387.","journal-title":"JAMA"},{"issue":"23","key":"4623_CR3","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","volume":"376","author":"CW Seymour","year":"2017","unstructured":"Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS, et al. Time to treatment and mortality during mandated emergency care for Sepsis. N Engl J Med. 2017;376(23):2235\u201344.","journal-title":"N Engl J Med"},{"issue":"8","key":"4623_CR4","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1001\/jama.2017.0131","volume":"317","author":"MD Howell","year":"2017","unstructured":"Howell MD, Davis AM. Management of Sepsis and Septic Shock. JAMA. 2017;317(8):847\u20138.","journal-title":"JAMA"},{"key":"4623_CR5","unstructured":"Antibiotic resistance threats in the United States, 2013: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2013. Available from: https:\/\/www.cdc.gov\/drugresistance\/pdf\/ar-threats-2013-508.pdf"},{"issue":"11","key":"4623_CR6","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1086\/647952","volume":"49","author":"JH Jorgensen","year":"2009","unstructured":"Jorgensen JH, Ferraro MJ. Antimicrobial susceptibility testing: a review of general principles and contemporary practices. Clin Infect Dis. 2009;49(11):1749\u201355.","journal-title":"Clin Infect Dis"},{"key":"4623_CR7","volume-title":"Direct identification of 80% of bacteria from blood culture bottles by MALDI-TOF MS using a 10-minute extraction protocol","author":"L Simon","year":"2018","unstructured":"Simon L, Ughetto E, Gaudart A, Degand N, Lotte R, Ruimy RJJoCM. Direct identification of 80% of bacteria from blood culture bottles by MALDI-TOF MS using a 10-minute extraction protocol. 2018:JCM. 01278\u201318."},{"issue":"1","key":"4623_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12879-019-3709-9","volume":"19","author":"M Azrad","year":"2019","unstructured":"Azrad M, Keness Y, Nitzan O, Pastukh N, Tkhawkho L, Freidus V, et al. Cheap and rapid in-house method for direct identification of positive blood cultures by MALDI-TOF MS technology. BMC Infect Dis. 2019;19(1):72.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"4623_CR9","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.cmi.2018.05.007","volume":"24","author":"N Peker","year":"2018","unstructured":"Peker N, Couto N, Sinha B, Rossen JW. Diagnosis of bloodstream infections from positive blood cultures and directly from blood samples: recent developments in molecular approaches. Clin Microbiol Infect. 2018;24(9):944\u201355.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"4623_CR10","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10096-018-03445-3","volume":"38","author":"S Horing","year":"2019","unstructured":"Horing S, Massarani AS, Loffler B, Rodel J. Rapid antibiotic susceptibility testing in blood culture diagnostics performed by direct inoculation using the VITEK(R)-2 and BD Phoenix platforms. Eur J Clin Microbiol Infect Dis. 2019;38(3):471\u20138.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4623_CR11","doi-asserted-by":"publisher","unstructured":"Charnot-Katsikas A, Tesic V, Love N, Hill B, Bethel C, Boonlayangoor S, et al. Use of the Accelerate Pheno System for Identification and Antimicrobial Susceptibility Testing of Pathogens in Positive Blood Cultures and Impact on Time to Results and Workflow. J Clin Microbiol. 2018;56(1). https:\/\/doi.org\/10.1128\/JCM.01166-17.","DOI":"10.1128\/JCM.01166-17"},{"key":"4623_CR12","doi-asserted-by":"crossref","unstructured":"Sanchez-Carrillo C, Pescador P, Ricote R, Fuentes J, Losada C, Candela A, et al. Evaluation of the Alfred AST(R) system for rapid antimicrobial susceptibility testing directly from positive blood cultures. Eur J Clin Microbiol Infect Dis. 2019;38(9):1665\u201370.","DOI":"10.1007\/s10096-019-03595-y"},{"issue":"3","key":"4623_CR13","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/jac\/dkl535","volume":"59","author":"M Hallin","year":"2007","unstructured":"Hallin M, Denis O, Deplano A, De Mendonca R, De Ryck R, Rottiers S, et al. Genetic relatedness between methicillin-susceptible and methicillin-resistant Staphylococcus aureus: results of a national survey. J Antimicrob Chemother. 2007;59(3):465\u201372.","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"4623_CR14","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1093\/jac\/dkt065","volume":"68","author":"P Bogaerts","year":"2013","unstructured":"Bogaerts P, Rezende de Castro R, de Mendonca R, Huang TD, Denis O, Glupczynski Y. Validation of carbapenemase and extended-spectrum beta-lactamase multiplex endpoint PCR assays according to ISO 15189. J Antimicrob Chemother. 2013;68(7):1576\u201382.","journal-title":"J Antimicrob Chemother"},{"key":"4623_CR15","unstructured":"Clark RB. Verification and validation of procedures in the clinical microbiology laboratory: Cumitech 31A: American society for microbiology. Washington DC: ASM Press; 2009."},{"issue":"6","key":"4623_CR16","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","volume":"34","author":"A Kumar","year":"2006","unstructured":"Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589\u201396.","journal-title":"Crit Care Med"},{"issue":"3","key":"4623_CR17","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1128\/AAC.01823-12","volume":"57","author":"L Armand-Lefevre","year":"2013","unstructured":"Armand-Lefevre L, Angebault C, Barbier F, Hamelet E, Defrance G, Ruppe E, et al. Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother. 2013;57(3):1488\u201395.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"4623_CR18","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/cid\/cit498","volume":"57","author":"AM Huang","year":"2013","unstructured":"Huang AM, Newton D, Kunapuli A, Gandhi TN, Washer LL, Isip J, et al. Impact of rapid organism identification via matrix-assisted laser desorption\/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin Infect Dis. 2013;57(9):1237\u201345.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"4623_CR19","first-page":"216","volume":"69","author":"KK Perez","year":"2014","unstructured":"Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Peterson LE, et al. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant gram-negative bacteremia. J Inf Secur. 2014;69(3):216\u201325.","journal-title":"J Inf Secur"},{"key":"4623_CR20","doi-asserted-by":"publisher","first-page":"827416","DOI":"10.1155\/2015\/827416","volume":"2015","author":"NG Morgenthaler","year":"2015","unstructured":"Morgenthaler NG, Kostrzewa M. Rapid identification of pathogens in positive blood culture of patients with sepsis: review and meta-analysis of the performance of the sepsityper kit. Int J Microbiol. 2015;2015:827416.","journal-title":"Int J Microbiol"},{"key":"4623_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1471-2180-11-156","volume":"11","author":"J Beuving","year":"2011","unstructured":"Beuving J, van der Donk CF, Linssen CF, Wolffs PF, Verbon A. Evaluation of direct inoculation of the BD PHOENIX system from positive BACTEC blood cultures for both gram-positive cocci and gram-negative rods. BMC Microbiol. 2011;11:156.","journal-title":"BMC Microbiol"},{"key":"4623_CR22","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3389\/fmicb.2018.00481","volume":"9","author":"HW Pan","year":"2018","unstructured":"Pan HW, Li W, Li RG, Li Y, Zhang Y, Sun EH. Simple sample preparation method for direct microbial identification and susceptibility testing from positive blood cultures. Front Microbiol. 2018;9:481.","journal-title":"Front Microbiol"},{"issue":"1","key":"4623_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12866-016-0805-5","volume":"16","author":"S Barnini","year":"2016","unstructured":"Barnini S, Brucculeri V, Morici P, Ghelardi E, Florio W, Lupetti A. A new rapid method for direct antimicrobial susceptibility testing of bacteria from positive blood cultures. BMC Microbiol. 2016;16(1):185.","journal-title":"BMC Microbiol"},{"key":"4623_CR24","doi-asserted-by":"publisher","first-page":"6976923","DOI":"10.1155\/2018\/6976923","volume":"2018","author":"C Giordano","year":"2018","unstructured":"Giordano C, Piccoli E, Brucculeri V, Barnini S. A prospective evaluation of two rapid Phenotypical antimicrobial susceptibility Technologies for the Diagnostic Stewardship of Sepsis. Biomed Res Int. 2018;2018:6976923.","journal-title":"Biomed Res Int"},{"issue":"4","key":"4623_CR25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1136\/ebmed-2014-110122","volume":"20","author":"PA Moise","year":"2015","unstructured":"Moise PA, Sakoulas G. Staphylococcus aureus bacteraemia management: where do we stand and where are we going? Evid Based Med. 2015;20(4):126.","journal-title":"Evid Based Med"},{"issue":"6","key":"4623_CR26","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1099\/jmm.0.000259","volume":"65","author":"V Menon","year":"2016","unstructured":"Menon V, Lahanas S, Janto C, Lee A. Utility of direct susceptibility testing on blood cultures: is it still worthwhile? J Med Microbiol. 2016;65(6):501\u20139.","journal-title":"J Med Microbiol"},{"issue":"5","key":"4623_CR27","doi-asserted-by":"publisher","first-page":"e0156299","DOI":"10.1371\/journal.pone.0156299","volume":"11","author":"A Verroken","year":"2016","unstructured":"Verroken A, Defourny L, le Polain de Waroux O, Belkhir L, Laterre PF, Delmee M, et al. Clinical impact of MALDI-TOF MS identification and rapid susceptibility testing on adequate antimicrobial treatment in Sepsis with positive blood cultures. PLoS One. 2016;11(5):e0156299.","journal-title":"PLoS One"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4623-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4623-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4623-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T01:04:13Z","timestamp":1605834253000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4623-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4623"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4623-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,21]]},"assertion":[{"value":"18 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Testing was performed in accordance with the ethical standards of the Cliniques universitaires Saint-Luc, in accordance with the ethical standards of the national research committee and in accordance with the 1964 Helsinki declaration and its later amendments. Microbiological data was collected from the laboratory information system and anonymously analyzed. This did not require patient\u2019s informed consent. No approval from the ethics committee was further required as testing was performed on residual samples and results were not used for patient\u2019s therapeutic management.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"989"}}